177 related articles for article (PubMed ID: 20959655)
1. CD200 (OX-2 membrane glycoprotein) expression in b cell-derived neoplasms.
Dorfman DM; Shahsafaei A
Am J Clin Pathol; 2010 Nov; 134(5):726-33. PubMed ID: 20959655
[TBL] [Abstract][Full Text] [Related]
2. CD200 (OX-2 membrane glycoprotein) is expressed by follicular T helper cells and in angioimmunoblastic T-cell lymphoma.
Dorfman DM; Shahsafaei A
Am J Surg Pathol; 2011 Jan; 35(1):76-83. PubMed ID: 21164290
[TBL] [Abstract][Full Text] [Related]
3. CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia.
Palumbo GA; Parrinello N; Fargione G; Cardillo K; Chiarenza A; Berretta S; Conticello C; Villari L; Di Raimondo F
Leuk Res; 2009 Sep; 33(9):1212-6. PubMed ID: 19230971
[TBL] [Abstract][Full Text] [Related]
4. CD2 is expressed by a subpopulation of normal B cells and is frequently present in mature B-cell neoplasms.
Kingma DW; Imus P; Xie XY; Jasper G; Sorbara L; Stewart C; Stetler-Stevenson M
Cytometry; 2002 Oct; 50(5):243-8. PubMed ID: 12360573
[TBL] [Abstract][Full Text] [Related]
5. CD200 flow cytometric assessment and semiquantitative immunohistochemical staining distinguishes hairy cell leukemia from hairy cell leukemia-variant and other B-cell lymphoproliferative disorders.
Pillai V; Pozdnyakova O; Charest K; Li B; Shahsafaei A; Dorfman DM
Am J Clin Pathol; 2013 Oct; 140(4):536-43. PubMed ID: 24045551
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of a new CD5 antibody for the diagnosis of T-cell and B-cell lymphoproliferative disorders in paraffin sections.
Dorfman DM; Shahsafaei A
Mod Pathol; 1997 Sep; 10(9):859-63. PubMed ID: 9310947
[TBL] [Abstract][Full Text] [Related]
7. Role of CD200 in differential diagnosis of mature B-cell neoplasm.
Rahman K; Kumar P; Gupta R; Singh MK; Nityanand S
Int J Lab Hematol; 2017 Aug; 39(4):384-391. PubMed ID: 28422443
[TBL] [Abstract][Full Text] [Related]
8. CD200 Expression in Diagnostic and Prognostic Assessment of Mature B Cell Lymphophoproliferative Neoplasms.
El Din Fouad NB; Ibrahim NY; Abdel Aziz RS; Ibrahim SK
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3383-3392. PubMed ID: 30583344
[TBL] [Abstract][Full Text] [Related]
9. [Expression of beta 1 integrins in normal B lymphocytes at different stages of development and in B cell neoplasias].
Eichelmann A; Koretz K; Mechtersheimer G; Möller P
Verh Dtsch Ges Pathol; 1992; 76():230-6. PubMed ID: 1283265
[TBL] [Abstract][Full Text] [Related]
10. Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.
Xerri L; Chetaille B; Serriari N; Attias C; Guillaume Y; Arnoulet C; Olive D
Hum Pathol; 2008 Jul; 39(7):1050-8. PubMed ID: 18479731
[TBL] [Abstract][Full Text] [Related]
11. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
12. Absence of surface CD27 distinguishes hairy cell leukemia from other leukemic B-cell malignancies.
Forconi F; Raspadori D; Lenoci M; Lauria F
Haematologica; 2005 Feb; 90(2):266-8. PubMed ID: 15710587
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotyping and differential diagnosis of hairy cell leukemia.
Matutes E
Hematol Oncol Clin North Am; 2006 Oct; 20(5):1051-63. PubMed ID: 16990106
[TBL] [Abstract][Full Text] [Related]
14. CD200 expression in B-cell chronic lymphoproliferative disorders.
El Desoukey NA; Afify RA; Amin DG; Mohammed RF
J Investig Med; 2012 Jan; 60(1):56-61. PubMed ID: 22064604
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of cyclin D1 using optimized conditions is highly specific for mantle cell lymphoma and hairy cell leukemia.
Miranda RN; Briggs RC; Kinney MC; Veno PA; Hammer RD; Cousar JB
Mod Pathol; 2000 Dec; 13(12):1308-14. PubMed ID: 11144927
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders.
Cabezudo E; Carrara P; Morilla R; Matutes E
Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919
[TBL] [Abstract][Full Text] [Related]
17. B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules.
Trentin L; Zambello R; Sancetta R; Facco M; Cerutti A; Perin A; Siviero M; Basso U; Bortolin M; Adami F; Agostini C; Semenzato G
Cancer Res; 1997 Nov; 57(21):4940-7. PubMed ID: 9354461
[TBL] [Abstract][Full Text] [Related]
18. P53 protein expression in human leukemia and lymphoma cells.
Koníková E; Kusenda J
Neoplasma; 2001; 48(4):290-8. PubMed ID: 11712681
[TBL] [Abstract][Full Text] [Related]
19. p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies.
Kremer M; Dirnhofer S; Nickl A; Hoefler H; Quintanilla-Martínez L; Fend F
Mod Pathol; 2001 Oct; 14(10):1022-9. PubMed ID: 11598173
[TBL] [Abstract][Full Text] [Related]
20. B cell neoplasms.
Skoog L; Tani E
Monogr Clin Cytol; 2009; 18():19-37. PubMed ID: 19092260
[No Abstract] [Full Text] [Related]
[Next] [New Search]
